首页 | 官方网站   微博 | 高级检索  
     

局部复发鼻咽癌调强放疗与常规放疗的疗效比较
引用本文:马文娟,张金山,曹卡加,夏伟雄.局部复发鼻咽癌调强放疗与常规放疗的疗效比较[J].中华放射肿瘤学杂志,2012,21(4):298-301.
作者姓名:马文娟  张金山  曹卡加  夏伟雄
作者单位:510060 广州,华南肿瘤学国家重点实验室中山大学肿瘤防治中心鼻咽科(马文娟、张金山现单位510150广州医学院第三附属医院放疗科)
摘    要:目的 比较调强放疗(IMRT)与二维常规放疗(2DCRT)治疗局部复发鼻咽癌的疗效及不良反应发生率。方法 292例局部复发鼻咽癌患者中,81例2DCRT,211例IMRT。采用UICC 2009年分期标准进行复发再分期。Kaplan-Meier法计算生存率并Logrank法检验,Cox法多因素预后分析。结果 随访率为91.8%,随访时间满 3年者2DCR、IMRT者分别为38、106例。2DCRT、IMRT者 3年总生存率不同(36.9%、51.3%,χ2=8.44,P=0.004),无局部进展生存率也不同(63.3%、86.0%,χ2=13.83,P=0.000),无远处转移生存率相似(79.0%、83.5%,χ2=0.25,P=0.618)。多因素分析结果显示T分期、IMRT是影响总生存和无局部进展生存的因素(χ2=9.51、5.20,P=0.002、0.023和 χ2=4.84、9.24,P=0.027、0.002)。2DCRT组3+4级张口困难和放射性脑病发生率高于IMRT组的(43.2%和24.7%∶19.9%和8.1%,χ2=16.37,P=0.000和 χ2=14.64,P=0.000),而IMRT鼻咽黏膜坏死和(或)鼻咽大出血的发生率高于2DCRT的(33.2%∶7.4%,χ2=20.19,P=0.000)。结论 IMRT可提高局部复发鼻咽癌患者的无局部进展生存率和总生存率,IMRT还可降低局部复发鼻咽癌患者再程放疗严重张口困难和放射性脑病发生率,但增加鼻咽黏膜溃疡和(或)鼻咽大出血发生率。

关 键 词:肿瘤复发  鼻咽/放射疗法  放射疗法  二维常规  放射疗法  调强  预后  
收稿时间:2011-12-31

Comparison of effectiveness of intensity-modulated radiotherapy with conventional two-dimensional radiotherapy for patients with locally recurrent nasopharyngeal carcinoma
MA Wen-juan , ZHANG Jin-shan , CAO Ka-jia , XIA Wei-xiong.Comparison of effectiveness of intensity-modulated radiotherapy with conventional two-dimensional radiotherapy for patients with locally recurrent nasopharyngeal carcinoma[J].Chinese Journal of Radiation Oncology,2012,21(4):298-301.
Authors:MA Wen-juan  ZHANG Jin-shan  CAO Ka-jia  XIA Wei-xiong
Affiliation:Departments of Radiation Oncology, Cancer Center, Sun Yat-sen University, State Key Laboratory of Oncology in South China, Guangzhou 510060, China;Corresponding author:CAO Ka-jia, Email:caokajia@163.com
Abstract:Objective To compare the efficacy and side-effects in locally recurrent nasopharyngeal carcinoma (NPC) treated by intensity-modulated radiotherapy (IMRT) and two-dimensional conventional radiotherapy (2DCRT). Methods Among the 292 newly diagnosed, nonmetastatic recurrent NPC, 211 were treated with IMRT and 81 with 2DCRT. All patients were staged according to the seventh edition of the UICC 2009 staging system. Kaplan-Meier and Logrank methods were used for survival analysis. A Cox proportional hazard model was used to examine prognostic factors. Results The follow-up rate was 91.8%, there are 38 patients in 2DCRT and 106 patients in IMRT group was followed more than 3 years. There were significant differences in the 3-year actuarial overall survival (OS) rate (36.9% and 51.3%,χ2=8.44,P=0.004) and local progression-free survival (LRFS) rate (63.3% and 86.0%,χ2=13.83,P=0.000), and no significant differences in actuarial distant metastasis free survival rates (79.0% and 83.5%,χ2=0.25,P=0.618) between the 2DCRT group and the IMRT group. Multivariate analysis showed that T category and IMRT (yes vs. no) were the independently prognostic factors for OS and LRFS (χ2=9.51, 5.20, P=0.002, 0.023 and χ2=4.84, 9.24, P=0.027, 0.002). The incidence of grade 3and4 trismus and radiation-induced encephalopathy were 19.9%, 8.1% for the IMRT group and 43.2%, 24.7% for the 2DCRT group (χ2=16.37,P=0.000 and χ2=14.64,P=0.000). Whereas, severe mucosa necrosis and/or massive hemorrhage in the nasopharynx was observed in IMRT group which was not common in 2DCRT (33.2%∶7.4%,χ2=20.19,P=0.000). Conclusions Higher local tumor control and overall survival were achieved by IMRT than 2DCRT, the incidence of severe trismus and radiation-induced encephalopathy was also reduced by IMRT, in cost of a higher incidence of mucosa necrosis and/or massive hemorrhage in the nasopharynx.
Keywords:Neoplasms recurrence  nasopharyngeal  Radiotherapy  two-dimensional conventional  Radiotherapy  intensity-modulated  Prognosis
本文献已被 万方数据 等数据库收录!
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号